Bain Capital Public Equity Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q4
Sell
-266,141
Closed -$16.9M 63
2013
Q3
$16.9M Buy
+266,141
New +$16.9M 0.42% 40